Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations.
Authors:
- S O BrennanSBS O Brennan
- M GallianoMGM Galliano
- O SugitaOSO Sugita
- 1 February 1990
- journal article
- research article
- Published by Elsevier in Molecular Pharmacology
- Vol. 37 (2) , 238-242
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Amino acid substitutions in genetic variants of human serum albumin and in sequences inferred from molecular cloning.Proceedings of the National Academy of Sciences, 1987
- The molecular abnormality of albumin Niigata: 269 Asp → GlyClinica Chimica Acta, 1987
- Albumin Canterbury (313 Lys → Asn). A point mutation in the second domain of serum albuminBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1987
- The molecular abnormality of albumin Parklands: 365 Asp → HisBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1985
- Relations between high-affinity binding sites of markers for binding regions on human serum albuminBiochemical Journal, 1985
- Relations between high-affinity binding sites for l-tryptophan, diazepam, salicylate and Phenol Red on human serum albuminBiochemical Journal, 1983
- BINDING OF DRUGS TO HUMAN-SERUM ALBUMIN .11. SPECIFICITY OF 3 BINDING-SITES AS STUDIED WITH ALBUMIN IMMOBILIZED IN MICROPARTICLES1979
- Reduced Warfarin Binding of Albumin VariantsScience, 1977
- Removal of Fatty Acids from Serum Albumin by Charcoal TreatmentJournal of Biological Chemistry, 1967
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951